{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Morus alba", "T2DM control", "Type 2 Diabetes Mellitus", "blood glucose"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34912543", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["1022", "10.12688/f1000research.55573.1"], "Journal": {"ISSN": "2046-1402", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2021"}}, "Title": "F1000Research", "ISOAbbreviation": "F1000Res"}, "ArticleTitle": "Medicinal properties of <i>Morus alba</i> for the control of type 2\u00a0diabetes\u00a0mellitus: a systematic review.", "Pagination": {"StartPage": "1022", "MedlinePgn": "1022"}, "Abstract": {"AbstractText": ["<b>Background:</b> The objective of this review was to evaluate the medicinal potential of <i>Morus alba</i> leaves on the control of type 2 diabetes mellitus (DM2). The research question was: what is the therapeutic potential of <i>Morus alba</i> leaves for the control of DM2? <b>Methods:</b> This systematic review was based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The included studies were extracted from Scopus, Pubmed, ScienceDirect, Scielo, and Google Scholar; January 2015 to July 2021. Key search terms were MeSH and DeCS: <i>Morus alba</i>, mulberry, hypoglycemic agent. The inclusion criteria were: studies in rats administered <i>Morus alba</i> leaf extracts; studies that included the dimensions of lipidemia and glycemia; studies that included indicators such as fasting glucose, postprandial glucose, glycosylated hemoglobin, triglycerides, low-density lipoproteins, total cholesterol, and insulin resistance. Exclusion criteria: studies in which <i>Morus alba</i> leaves were administered with other plants; studies with other parts of the <i>Morus alba</i> plant; proteomic studies, cancer, duplicate studies, <i>in vitro</i> studies, and evaluation of included studies. All included investigations were evaluated for biases. <b>Results:</b> Of 253 studies found, 29 were included. The extracts of <i>Morus alba</i> leaves at the phytochemical level improve glucose uptake. Chlorogenic acid, isoquercitrin, and quercitrin, present in the leaves of <i>Morus alba</i>, have hypoglycemic properties and an ameliorating effect on diabetic nephropathy. This leaf has pharmacological effects such as glucose absorption, insulin secretion production, antioxidant and anti-inflammatory agent, antihyperglycemic and antihyperlipidemic activities, and obesity management. <b>Conclusions:</b><i>Morus alba</i> leaves have pharmacological effects on DM2 that include glucose absorption, production of insulin secretion, antioxidant agent, antihyperglycemic and antihyperlipidemic activities, and obesity control. Beyond these results, there is a lack of studies on the potential and synergistic effects of <i>Morus alba</i> leaves' components, limiting the possibility of a more effective therapy using the plant's leaves."], "CopyrightInformation": "Copyright: \u00a9 2021 Morales Ramos JG et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad Se\u00f1or de Sip\u00e1n S.A.C., Chiclayo, Per\u00fa, Lambayeque, 14001, Peru."}], "LastName": "Morales Ramos", "ForeName": "Jorge Guillermo", "Initials": "JG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad Privada Norbert Wiener, Chiclayo, Per\u00fa, Lambayeque, 14001, Peru."}], "LastName": "Esteves Pairazam\u00e1n", "ForeName": "Ambrocio Teodoro", "Initials": "AT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad Se\u00f1or de Sip\u00e1n S.A.C., Chiclayo, Per\u00fa, Lambayeque, 14001, Peru."}], "LastName": "Mocarro Willis", "ForeName": "Mar\u00eda Ema Soledad", "Initials": "MES"}, {"Identifier": ["0000-0001-7910-4045"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad de San Mart\u00edn de Porres, Chiclayo, Per\u00fa, Lambayeque, 14001, Peru."}], "LastName": "Collantes Santisteban", "ForeName": "Samuel", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Universidad Privada Norbert Wiener, Chiclayo, Per\u00fa, Lambayeque, 14001, Peru."}], "LastName": "Caldas Herrera", "ForeName": "Emma", "Initials": "E"}], "PublicationTypeList": ["Research Support, Non-U.S. Gov't", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "F1000Res", "NlmUniqueID": "101594320", "ISSNLinking": "2046-1402"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Morus"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Proteomics"}, {"QualifierName": [], "DescriptorName": "Rats"}], "CoiStatement": "No competing interests were disclosed."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\nWHO:\nGlobal report on diabetes [Internet].\n\nWorld Health Organization, editor. Organizaci\u00f3n Mundial de la Salud.\n\n2016 [cited 2021 Aug 20].1\u201386p.\nReference Source\n"}, {"Citation": "\nWHO:\nDiabetes [Internet].\n\nWorld Health Organization.\n\n2021 [cited 2021 Aug 20].\nReference Source\n"}, {"Citation": "Saeedi P, Petersohn I, Salpea P, et al. : Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov [cited 2021 Aug 20];157:107843. 10.1016/j.diabres.2019.107843", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "\nRojas E, Molina R, Rodr\u00edguez C:\nDefinition, classification and diagnosis of diabetes mellitus.\n\nRev Venez Endocrinol y Metab.\n\n2012 [cited 2021 Aug 20];10(1):7\u201312.\n10.1055/s-0034-1366278\nReference Source\n", "ArticleIdList": ["10.1055/s-0034-1366278", "25014088"]}, {"Citation": "\nMellado-Orellana R, Salinas-Lezama E, S\u00e1nchez-Herrera D, et al. :\nPharmacological treatment of diabetes mellitus type 2 directed to patients with overweight and obesity.\n\nMed Interna M\u00e9xico.\n\n2019 Aug [cited 2021 Aug 20];35(4):525\u2013536.\nReference Source\n"}, {"Citation": "\nPolonsky KS:\nThe Past 200 Years in Diabetes.\n\nN Engl J Med.\n\n2012 Oct [cited 2021 Aug 20];367(14):1332\u20131340.\n10.1056/NEJMra1110560\nReference Source\n", "ArticleIdList": ["10.1056/nejmra1110560", "10.1056/NEJMra1110560", "23034021"]}, {"Citation": "\nSecl\u00e9n S:\nDiabetes mellitus in Peru where we are going.\n\nRev Medica Hered.\n\n2015 [cited 2021 Aug 20];26(1):3\u20134.\n10.1016/j.aogh.2015.12.018\nReference Source\n", "ArticleIdList": ["10.1016/j.aogh.2015.12.018", "27108144"]}, {"Citation": "Villena JE: Diabetes Mellitus in Peru. Ann Glob Heal. 2015 Nov [cited 2021 Aug 20];81(6):765\u2013775. 10.1016/j.aogh.2015.12.018", "ArticleIdList": ["10.1016/j.aogh.2015.12.018", "27108144"]}, {"Citation": "He X, Fang J, Ruan Y, et al. : Structures, bioactivities and future prospective of polysaccharides from Morus alba (white mulberry): A review. Food Chem. 2018 Apr 15 [cited 2021 Jul 16];245:899\u2013910. 10.1016/j.foodchem.2017.11.084", "ArticleIdList": ["10.1016/j.foodchem.2017.11.084", "29287458"]}, {"Citation": "Wei H, Liu S, Liao Y, et al. : A Systematic Review of the Medicinal Potential of Mulberry in Treating Diabetes Mellitus. Am J Chin Med. 2019 Jan 7 [cited 2021 Jul 16];46(8):1743\u20131770. 10.1142/S0192415X1850088X", "ArticleIdList": ["10.1142/S0192415X1850088X", "30518235"]}, {"Citation": "\nLim SH, Yu JS, Lee HS, et al. :\nAntidiabetic Flavonoids from Fruits of Morus alba Promoting Insulin-Stimulated Glucose Uptake via Akt and AMP-Activated Protein Kinase Activation in 3T3-L1 Adipocytes.\n\nPharm 2021, Vol 13, Page 526.\n\n2021 Apr 9 [cited 2021 Jul 9];13(4):526.\n10.3390/pharmaceutics13040526\n\nReference Source\n", "ArticleIdList": ["10.3390/pharmaceutics13040526", "PMC8069446", "33918969"]}, {"Citation": "\nYounus I, Fatima A, Ali SM, et al. :\nA Review of Ethnobotany, Phytochemistry, Antiviral and Cytotoxic/Anticancer Potential of Morus alba Linn.\n\nInt J Adv Res Rev.\n\n2016 [cited 2021 Jul 19];1(2):84\u201396.\nReference Source\n"}, {"Citation": "Chan EW-C, Lye P-Y, Wong S-K: Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin J Nat Med. 2016 Jan 1 [cited 2021 Jul 16];14(1):17\u201330. 10.3724/SP.J.1009.2016.00017", "ArticleIdList": ["10.3724/SP.J.1009.2016.00017", "26850343"]}, {"Citation": "\nLiberati A, Altman DG, Tetzlaff J, et al. :\nThe PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration.\n\nPLoS Med.\n\n2009 Jul 21 [cited 2020 Aug 16];6(7):1\u201328.\nReference Source\n", "ArticleIdList": ["10.1371/journal.pmed.1000100", "PMC2707010", "19621070"]}, {"Citation": "\nL\u00f3pez-L\u00f3pez E, Tob\u00f3n S, Ju\u00e1rez-Hern\u00e1ndez LG:\nScale to evaluate scientific articles in social and human sciences- SSAHS.\n\nRev Iberoam sobre Calidad, Efic y Cambio en Educ.\n\n2019 Sep 29 [cited 2020 Aug 30];17(4):111\u2013125.\nReference Source\n"}, {"Citation": "\nNational Heart, Lung, Blood Institut:\nStudy Quality Assessment Tools.\n2020 [cited 2020 Aug 18].\nReference Source\n"}, {"Citation": "Hwang SH, Li HM, Lim SS, et al. : Evaluation of a Standardized Extract from Morus alba against \u03b1-Glucosidase Inhibitory Effect and Postprandial Antihyperglycemic in Patients with Impaired Glucose Tolerance: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med. 2016 [cited 2021 Jul 19];2016. 10.1155/2016/8983232", "ArticleIdList": ["10.1155/2016/8983232", "PMC5128732", "27974904"]}, {"Citation": "Qi S, Li N, Tuo Z, et al. : Effects of Morus root bark extract and active constituents on blood lipids in hyperlipidemia rats. J Ethnopharmacol. 2016 Mar 2 [cited 2021 Jul 9];180:54\u201359. 10.1016/j.jep.2016.01.024", "ArticleIdList": ["10.1016/j.jep.2016.01.024", "26806569"]}, {"Citation": "\nTond SB, Fallah S, Salemi Z, et al. :\nInfluence of mulberry leaf extract on serum adiponectin, visfatin and lipid profile levels in type 2 diabetic rats.\n\nBrazilian Arch Biol Technol.\n\n2016 Jun 27 [cited 2021 Jul 16];59:1\u20139.\nReference Source\n"}, {"Citation": "Ge Q, Cheng L, Tang M, et al. : Analysis of mulberry leaf components in the treatment of Diabetes using network pharmacology. Eur J Pharmacol. 2018 Aug 15 [cited 2021 Jul 9]:833, 50\u2013862. 10.1016/j.ejphar.2018.05.021", "ArticleIdList": ["10.1016/j.ejphar.2018.05.021", "29782863"]}, {"Citation": "\nWen P, Hu TG, Linhardt RJ, et al. :\nMulberry: A review of bioactive compounds and advanced processing technology.\n\nTrends Food Sci Technol.\n\n2019 Jan 1 [cited 2021 Jul 16];83:138\u2013158.\nReference Source\n"}, {"Citation": "\nD\u00edaz SM, Caza\u00f1a MY, P\u00e9rez HY, et al. :\nQualitative evaluation of secondary metabolites in extracts of Morus alba L. (mulberry) varieties and hybrids.\n\nRev Cuba Plantas Med.\n\n2015 [cited 2021 Jul 16];20(3):358\u201366.\nReference Source\n"}, {"Citation": "Go EJ, Ryu BR, Yang SJ, et al. : Anti-obesity Effect of the Flavonoid Rich Fraction from Mulberry Leaf Extract. Korean J Med Crop Sci. 2020 [cited 2021 Jul 16];28(6):395\u2013411. 10.7783/KJMCS.2020.28.6.395", "ArticleIdList": ["10.7783/KJMCS.2020.28.6.395"]}, {"Citation": "\nSwathi P, Gana Manjusha K, Vivekanand M, et al. :\nEffect of Morus alba against Hyperglycemic and Hyperlipidemic Activities in Streptozotocin Induced Diabetic Nephropathy.\n\nBiosci Biotechnol Res Asia.\n\n2017 Dec 28 [cited 2021 Jul 16];14(4):1441\u20131447.\nReference Source\n"}, {"Citation": "Ji S, Zhu C, Gao S, et al. : Morus alba leaves ethanol extract protects pancreatic islet cells against dysfunction and death by inducing autophagy in type 2 diabetes. Phytomedicine. 2021 Mar 1 [cited 2021 Jul 9];83. 10.1016/j.phymed.2021.153478", "ArticleIdList": ["10.1016/j.phymed.2021.153478", "33567371"]}, {"Citation": "\nMahesh DS, Vidhathri BS, Vidyashree DN, et al. :\nBiochemical Composition and Pharmacological Properties of Mulberry (Morus spp.) - A Review.\n\nInt J Curr Microbiol Appl Sci.\n\n2017 Jul 20 [cited 2021 Jul 9];6(7):2207\u201317.\nReference Source\n"}, {"Citation": "\nLiu C, Xiang W, Yu Y, et al. :\nComparative analysis of 1-deoxynojirimycin contribution degree to \u03b1-glucosidase inhibitory activity and physiological distribution in Morus alba L.\n\nInd Crops Prod.\n\n2015 Aug 1 [cited 2021 Jul 16];70:309\u2013315.\nReference Source\n"}, {"Citation": "\nJeszka-Skowron M, Flaczyk E, Jeszka J, et al. :\nMulberry leaf extract intake reduces hyperglycaemia in streptozotocin (STZ)-induced diabetic rats fed high-fat diet.\n\nJ Funct Foods.\n\n2014 May 1 [cited 2021 Jul 16];8(1):9\u201317.\nReference Source\n"}, {"Citation": "Wilson RD, Islam MS: Effects of white mulberry (Morus alba) leaf tea investigated in a type 2 diabetes model of rats. Acta Pol Pharm. 2015 [cited 2021 Jul 16];72(1):153\u2013160.", "ArticleIdList": ["25850211"]}, {"Citation": "\nAhn E, Lee J, Jeon Y-H, et al. :\nAnti-diabetic effects of mulberry (Morus alba L.) branches and oxyresveratrol in streptozotocin-induced diabetic mice.\n\nFood Sci Biotechnol 2017 266.\n\n2017 Dec 12 [cited 2021 Jul 9];26(6):1693\u20131702.\n10.1007/s10068-017-0223-y\n\nReference Source\n", "ArticleIdList": ["10.1007/s10068-017-0223-y", "10.1007/s10068-017-0223-y", "PMC6049727", "30263707"]}, {"Citation": "\nMeng Q, Qi X, Chao Y, et al. :\nIRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3-L1 adipocytes.\n\nChin Med.\n\n2020 Jan 2 [cited 2021 Jul 19];15(1):1\u201311.\n10.1186/s13020-019-0281-6\n\nReference Source\n", "ArticleIdList": ["10.1186/s13020-019-0281-6", "10.1186/s13020-019-0281-6", "PMC6941306", "31908653"]}, {"Citation": "\nKhyade VB:\nInfluence of Leaf Decoction of Mulberry, Morus alba (L.) on Streptozotocin Induced Diabetes in Brown Rat, Rattus norvegicus (L.).\n\nInt J Res Sci Eng.\n\n2018 [cited 2021 Jul 9];6(3):1\u201323.\nReference Source\n"}, {"Citation": "Kr\u00f3l E, Jeszka-Skowron M, Krejpcio Z, et al. : The Effects of Supplementary Mulberry Leaf (Morus alba) Extracts on the Trace Element Status (Fe, Zn and Cu) in Relation to Diabetes Management and Antioxidant Indices in Diabetic Rats. Biol Trace Elem Res. 2016 Nov 1 [cited 2021 Jul 9];174(1):158\u2013165. 10.1007/s12011-016-0696-1", "ArticleIdList": ["10.1007/s12011-016-0696-1", "PMC5055558", "27071614"]}, {"Citation": "Meng Q, Qi X, Fu Y, et al. : Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes. J Ethnopharmacol. 2020 Feb 10 [cited 2021 Jul 19]:248. 10.1016/j.jep.2019.112326", "ArticleIdList": ["10.1016/j.jep.2019.112326", "31639486"]}, {"Citation": "Hwang SH, Li HM, Lim SS, et al. : Evaluation of a Standardized Extract from Morus alba against \u03b1-Glucosidase Inhibitory Effect and Postprandial Antihyperglycemic in Patients with Impaired Glucose Tolerance: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med. 2016 [cited 2021 Jul 9];2016. 10.1155/2016/8983232", "ArticleIdList": ["10.1155/2016/8983232", "PMC5128732", "27974904"]}, {"Citation": "Kan J, Velliquette RA, Grann K, et al. : A novel botanical formula prevents Diabetes by improving insulin resistance. BMC Complement Altern Med. 2017 Jul 5 [cited 2021 Jul 19];17(1). 10.1186/s12906-017-1848-3", "ArticleIdList": ["10.1186/s12906-017-1848-3", "PMC5499036", "28679380"]}, {"Citation": "Rodrigues EL, Marcelino G, Silva GT, et al. : Nutraceutical and Medicinal Potential of the Morus Species in Metabolic Dysfunctions. Int J Mol Sci. 2019 Jan 2 [cited 2021 Jul 19];20(2). 10.3390/ijms20020301", "ArticleIdList": ["10.3390/ijms20020301", "PMC6358891", "30646503"]}, {"Citation": "\nKar A, Mukherjee PK, Sankarshan S, et al. :\nPossible herb-drug interaction of Morus alba L. - a potential antidiabetic plant from Indian traditional medicine.\n\nIndian J Tradit Knowl.\n\n2015 [cited 2021 Jul 16];14(4):626\u2013631.\nReference Source\n"}, {"Citation": "Jiao Y, Wang X, Jiang X, et al. : Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats. J Ethnopharmacol. 2017 Feb 2 [cited 2021 Jul 9];199:119\u2013127. 10.1016/j.jep.2017.02.003", "ArticleIdList": ["10.1016/j.jep.2017.02.003", "28163112"]}, {"Citation": "Mahboubi M: Morus alba (mulberry), a natural potent compound in management of obesity. Pharmacol Res. 2019 Aug 1 [cited 2021 Jul 19]:146. 10.1016/j.phrs.2019.104341", "ArticleIdList": ["10.1016/j.phrs.2019.104341", "31276774"]}, {"Citation": "Ramos JGM, Pairazam\u00e1n ATE, Willis MESM, et al. : Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review [Data set]. Zenodo. 2021. 10.5281/zenodo.5252877", "ArticleIdList": ["10.5281/zenodo.5252877"]}, {"Citation": ": Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas. Revista Espa\u00f1ola de Cardiolog\u00eda .2021;74(9) : 10.1016/j.recesp.2021.06.016 790-799 10.1016/j.recesp.2021.06.016", "ArticleIdList": ["10.1016/j.recesp.2021.06.016", "34446261"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "31"}, {"Year": "2021", "Month": "12", "Day": "16", "Hour": "6", "Minute": "33"}, {"Year": "2021", "Month": "12", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["34912543", "PMC8593624", "10.12688/f1000research.55573.1"]}}], "PubmedBookArticle": []}